ANASTROZOLE NEAPOLIS 1 MG BT 30
Product information
Treatment of advanced hormone receptor-positive breast cancer in postmenopausal women.
Adjuvant treatment of early-stage invasive hormone receptor-positive breast cancer in postmenopausal women.
Adjuvant treatment of early-stage invasive hormone receptor-positive breast cancer in postmenopausal women who have received adjuvant treatment with tamoxifen for 2 to 3 years.
We are working on other therapeutic areas
Learn more about our medicines
